img

Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

An angiotensin-converting-enzyme inhibitor (ACE inhibitor) is a pharmaceutical drug used primarily for the treatment of hypertension (elevated blood pressure) and congestive heart failure.
Angiotensin Converting Enzyme (ACE) Inhibitors report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Angiotensin Converting Enzyme (ACE) Inhibitors market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hypertension and Cardiovascular Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Angiotensin Converting Enzyme (ACE) Inhibitors industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Angiotensin Converting Enzyme (ACE) Inhibitors key manufacturers include Abbott Laboratories, Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi and Bristol-Myers Squibb, etc. Abbott Laboratories, Pfizer, Novartis are top 3 players and held % sales share in total in 2022.
Angiotensin Converting Enzyme (ACE) Inhibitors can be divided into Sulfhydryl-containing Agents, Dicarboxylate-containing Agents and Phosphonate-containing Agents,, etc. Sulfhydryl-containing Agents is the mainstream product in the market, accounting for % sales share globally in 2022.
Angiotensin Converting Enzyme (ACE) Inhibitors is widely used in various fields, such as Hypertension, Cardiovascular Diseases, Kidney Diseases and Other, etc. Hypertension provides greatest supports to the Angiotensin Converting Enzyme (ACE) Inhibitors industry development. In 2022, global % sales of Angiotensin Converting Enzyme (ACE) Inhibitors went into Hypertension filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Angiotensin Converting Enzyme (ACE) Inhibitors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Abbott Laboratories
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Segment by Type
Sulfhydryl-containing Agents
Dicarboxylate-containing Agents
Phosphonate-containing Agents

Segment by Application


Hypertension
Cardiovascular Diseases
Kidney Diseases
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Angiotensin Converting Enzyme (ACE) Inhibitors market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Angiotensin Converting Enzyme (ACE) Inhibitors, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Angiotensin Converting Enzyme (ACE) Inhibitors industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Angiotensin Converting Enzyme (ACE) Inhibitors in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Angiotensin Converting Enzyme (ACE) Inhibitors introduction, etc. Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Angiotensin Converting Enzyme (ACE) Inhibitors market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Angiotensin Converting Enzyme (ACE) Inhibitors Market Overview
1.1 Angiotensin Converting Enzyme (ACE) Inhibitors Product Overview
1.2 Angiotensin Converting Enzyme (ACE) Inhibitors Market Segment by Type
1.2.1 Sulfhydryl-containing Agents
1.2.2 Dicarboxylate-containing Agents
1.2.3 Phosphonate-containing Agents
1.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Type
1.3.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Overview by Type (2018-2034)
1.3.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Size Review by Type (2018-2024)
1.3.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2018-2024)
2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Competition by Company
2.1 Global Top Players by Angiotensin Converting Enzyme (ACE) Inhibitors Sales (2018-2024)
2.2 Global Top Players by Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (2018-2024)
2.3 Global Top Players by Angiotensin Converting Enzyme (ACE) Inhibitors Price (2018-2024)
2.4 Global Top Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Angiotensin Converting Enzyme (ACE) Inhibitors Market Competitive Situation and Trends
2.5.1 Angiotensin Converting Enzyme (ACE) Inhibitors Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angiotensin Converting Enzyme (ACE) Inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into Angiotensin Converting Enzyme (ACE) Inhibitors Market
2.8 Key Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Angiotensin Converting Enzyme (ACE) Inhibitors Status and Outlook by Region
3.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Size by Region
3.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Region (2018-2024)
3.2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Region (2018-2024)
3.2.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Forecasted Market Size by Region
3.3.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Region (2024-2034)
3.3.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Region (2024-2034)
3.3.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Angiotensin Converting Enzyme (ACE) Inhibitors by Application
4.1 Angiotensin Converting Enzyme (ACE) Inhibitors Market Segment by Application
4.1.1 Hypertension
4.1.2 Cardiovascular Diseases
4.1.3 Kidney Diseases
4.1.4 Other
4.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Application
4.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Overview by Application (2018-2034)
4.2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Size Review by Application (2018-2024)
4.2.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application (2018-2024)
5 North America Angiotensin Converting Enzyme (ACE) Inhibitors by Country
5.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Size by Country
5.1.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2018-2024)
5.1.3 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Country (2018-2024)
5.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Forecasted Market Size by Country
5.2.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2024-2034)
5.2.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Country (2024-2034)
6 Europe Angiotensin Converting Enzyme (ACE) Inhibitors by Country
6.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Size by Country
6.1.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2018-2024)
6.1.3 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Country (2018-2024)
6.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Forecasted Market Size by Country
6.2.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2024-2034)
6.2.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Country (2024-2034)
7 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors by Region
7.1 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Region (2024-2034)
8 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors by Country
8.1 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Size by Country
8.1.1 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2018-2024)
8.1.3 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Country (2018-2024)
8.2 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Forecasted Market Size by Country
8.2.1 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2024-2034)
8.2.2 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Country (2024-2034)
9 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors by Country
9.1 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Information
10.1.2 Abbott Laboratories Introduction and Business Overview
10.1.3 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
10.1.5 Abbott Laboratories Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
10.2.5 Pfizer Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
10.3.5 Novartis Recent Development
10.4 Merck
10.4.1 Merck Company Information
10.4.2 Merck Introduction and Business Overview
10.4.3 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
10.4.5 Merck Recent Development
10.5 Astra Zeneca
10.5.1 Astra Zeneca Company Information
10.5.2 Astra Zeneca Introduction and Business Overview
10.5.3 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
10.5.5 Astra Zeneca Recent Development
10.6 Jhonson and Johnson
10.6.1 Jhonson and Johnson Company Information
10.6.2 Jhonson and Johnson Introduction and Business Overview
10.6.3 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
10.6.5 Jhonson and Johnson Recent Development
10.7 Eli Lilly
10.7.1 Eli Lilly Company Information
10.7.2 Eli Lilly Introduction and Business Overview
10.7.3 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
10.7.5 Eli Lilly Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
10.8.5 Sanofi Recent Development
10.9 Bristol-Myers Squibb
10.9.1 Bristol-Myers Squibb Company Information
10.9.2 Bristol-Myers Squibb Introduction and Business Overview
10.9.3 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
10.9.5 Bristol-Myers Squibb Recent Development
10.10 Bayer
10.10.1 Bayer Company Information
10.10.2 Bayer Introduction and Business Overview
10.10.3 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
10.10.5 Bayer Recent Development
10.11 GSK
10.11.1 GSK Company Information
10.11.2 GSK Introduction and Business Overview
10.11.3 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.11.4 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
10.11.5 GSK Recent Development
10.12 Teva Pharmaceutical
10.12.1 Teva Pharmaceutical Company Information
10.12.2 Teva Pharmaceutical Introduction and Business Overview
10.12.3 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
10.12.5 Teva Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Angiotensin Converting Enzyme (ACE) Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Angiotensin Converting Enzyme (ACE) Inhibitors Industrial Chain Analysis
11.4 Angiotensin Converting Enzyme (ACE) Inhibitors Market Dynamics
11.4.1 Angiotensin Converting Enzyme (ACE) Inhibitors Industry Trends
11.4.2 Angiotensin Converting Enzyme (ACE) Inhibitors Market Drivers
11.4.3 Angiotensin Converting Enzyme (ACE) Inhibitors Market Challenges
11.4.4 Angiotensin Converting Enzyme (ACE) Inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Angiotensin Converting Enzyme (ACE) Inhibitors Distributors
12.3 Angiotensin Converting Enzyme (ACE) Inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Sulfhydryl-containing Agents
Table 2. Major Company of Dicarboxylate-containing Agents
Table 3. Major Company of Phosphonate-containing Agents
Table 4. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2018-2024) & (K MT)
Table 6. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2018-2024) & (US& Million)
Table 8. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share in Value by Type (2018-2024)
Table 9. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2018-2024) & (USD/MT)
Table 10. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2024-2034) & (K MT)
Table 11. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type (2024-2034)
Table 14. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2024-2034) & (USD/MT)
Table 15. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2018-2024) & (K MT)
Table 16. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) by Type (2018-2024)
Table 18. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) by Type (2018-2024)
Table 20. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) by Type (2018-2024)
Table 22. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) by Type (2018-2024)
Table 24. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2018-2024) & (K MT)
Table 26. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Company (2018-2024)
Table 27. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Company (2018-2024)
Table 29. Global Market Angiotensin Converting Enzyme (ACE) Inhibitors Price by Company (2018-2024) & (USD/MT)
Table 30. Global Angiotensin Converting Enzyme (ACE) Inhibitors Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angiotensin Converting Enzyme (ACE) Inhibitors as of 2022)
Table 33. Date of Key Manufacturers Enter into Angiotensin Converting Enzyme (ACE) Inhibitors Market
Table 34. Key Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2018-2024) & (K MT)
Table 38. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 41. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 42. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2024-2034) & (K MT)
Table 43. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Region (2024-2034)
Table 46. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 47. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2018-2024) & (K MT)
Table 49. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application (2018-2024)
Table 52. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2018-2024) & (USD/MT)
Table 53. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2024-2034) & (K MT)
Table 54. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application (2024-2034)
Table 57. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2024-2034) & (USD/MT)
Table 58. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2018-2024) (K MT)
Table 59. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2018-2024) (K MT)
Table 61. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2018-2024) (K MT)
Table 63. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2018-2024) (K MT)
Table 65. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2018-2024) (K MT)
Table 67. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2018-2024) & (K MT)
Table 69. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 72. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2024-2034) & (K MT)
Table 73. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2018-2024) & (K MT)
Table 77. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2024-2034) & (K MT)
Table 81. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2018-2024) & (K MT)
Table 85. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2024-2034) & (K MT)
Table 89. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2018-2024) & (K MT)
Table 93. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2024-2034) & (K MT)
Table 97. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2018-2024) & (K MT)
Table 101. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2024-2034) & (K MT)
Table 105. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 108. Abbott Laboratories Company Information
Table 109. Abbott Laboratories Introduction and Business Overview
Table 110. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 111. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Product
Table 112. Abbott Laboratories Recent Development
Table 113. Pfizer Company Information
Table 114. Pfizer Introduction and Business Overview
Table 115. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 116. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Product
Table 117. Pfizer Recent Development
Table 118. Novartis Company Information
Table 119. Novartis Introduction and Business Overview
Table 120. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 121. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Product
Table 122. Novartis Recent Development
Table 123. Merck Company Information
Table 124. Merck Introduction and Business Overview
Table 125. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 126. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Product
Table 127. Merck Recent Development
Table 128. Astra Zeneca Company Information
Table 129. Astra Zeneca Introduction and Business Overview
Table 130. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 131. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Product
Table 132. Astra Zeneca Recent Development
Table 133. Jhonson and Johnson Company Information
Table 134. Jhonson and Johnson Introduction and Business Overview
Table 135. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 136. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Product
Table 137. Jhonson and Johnson Recent Development
Table 138. Eli Lilly Company Information
Table 139. Eli Lilly Introduction and Business Overview
Table 140. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 141. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Product
Table 142. Eli Lilly Recent Development
Table 143. Sanofi Company Information
Table 144. Sanofi Introduction and Business Overview
Table 145. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 146. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Product
Table 147. Sanofi Recent Development
Table 148. Bristol-Myers Squibb Company Information
Table 149. Bristol-Myers Squibb Introduction and Business Overview
Table 150. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 151. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Product
Table 152. Bristol-Myers Squibb Recent Development
Table 153. Bayer Company Information
Table 154. Bayer Introduction and Business Overview
Table 155. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 156. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Product
Table 157. Bayer Recent Development
Table 158. GSK Company Information
Table 159. GSK Introduction and Business Overview
Table 160. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 161. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Product
Table 162. GSK Recent Development
Table 163. Teva Pharmaceutical Company Information
Table 164. Teva Pharmaceutical Introduction and Business Overview
Table 165. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 166. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Product
Table 167. Teva Pharmaceutical Recent Development
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Angiotensin Converting Enzyme (ACE) Inhibitors Market Trends
Table 171. Angiotensin Converting Enzyme (ACE) Inhibitors Market Drivers
Table 172. Angiotensin Converting Enzyme (ACE) Inhibitors Market Challenges
Table 173. Angiotensin Converting Enzyme (ACE) Inhibitors Market Restraints
Table 174. Angiotensin Converting Enzyme (ACE) Inhibitors Distributors List
Table 175. Angiotensin Converting Enzyme (ACE) Inhibitors Downstream Customers
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiotensin Converting Enzyme (ACE) Inhibitors Product Picture
Figure 2. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of Sulfhydryl-containing Agents
Figure 6. Global Sulfhydryl-containing Agents Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Dicarboxylate-containing Agents
Figure 8. Global Dicarboxylate-containing Agents Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Product Picture of Phosphonate-containing Agents
Figure 10. Global Phosphonate-containing Agents Sales YoY Growth (2018-2034) & (K MT)
Figure 11. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Type in 2022 & 2034
Figure 13. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 14. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type in 2022
Figure 15. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 16. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type in 2022
Figure 19. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Angiotensin Converting Enzyme (ACE) Inhibitors Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Angiotensin Converting Enzyme (ACE) Inhibitors Revenue in 2022
Figure 25. Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hypertension
Figure 27. Global Hypertension Sales YoY Growth (2018-2034) & (K MT)
Figure 28. Product Picture of Cardiovascular Diseases
Figure 29. Global Cardiovascular Diseases Sales YoY Growth (2018-2034) & (K MT)
Figure 30. Product Picture of Kidney Diseases
Figure 31. Global Kidney Diseases Sales YoY Growth (2018-2034) & (K MT)
Figure 32. Product Picture of Other
Figure 33. Global Other Sales YoY Growth (2018-2034) & (K MT)
Figure 34. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Application in 2022 & 2034
Figure 36. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 37. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application in 2022
Figure 38. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 39. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application in 2022
Figure 42. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturing Cost Structure
Figure 47. Angiotensin Converting Enzyme (ACE) Inhibitors Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries